2019
DOI: 10.1002/ccd.28117
|View full text |Cite
|
Sign up to set email alerts
|

Long‐term follow‐up of covered stent implantation for various coronary artery diseases

Abstract: Objectives The aims of this study were to evaluate the long‐term clinical outcomes after coronary covered stent (CS) implantation and to compare the results according to the indications. Background To date, data on the long‐term follow‐up of coronary CS are limited, and no studies have been conducted to compare outcomes on the basis of specific lesions treated. Methods A total of 190 consecutive patients (212 lesions) implanted with CS and surviving until discharge between May 1997 and February 2017 were enrol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
12
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 30 publications
(53 reference statements)
2
12
0
Order By: Relevance
“…Even more, the rates of TLR and ST continued to increase, up to 38.7 and 17.8% at 10 years, respectively. 19 In this regard, we describe a 16.2% rate of TLR and 7.7% ST rate during the first year.…”
Section: Discussionmentioning
confidence: 73%
See 1 more Smart Citation
“…Even more, the rates of TLR and ST continued to increase, up to 38.7 and 17.8% at 10 years, respectively. 19 In this regard, we describe a 16.2% rate of TLR and 7.7% ST rate during the first year.…”
Section: Discussionmentioning
confidence: 73%
“…18 In our study, CAA was the second most frequent indication for PKP, in accordance with recent reports of CS. 19,20 However, information regarding CS in CAA is heterogeneous and limited to small series of patients, highlighting the unmet need for a largescale registry in this setting.…”
Section: Discussionmentioning
confidence: 99%
“…The combination of multiple factors contributes to the increased risk of CAP and the subsequent adverse events such as pericardial effusion or cardiac tamponade: female sex, older age, calcified coronary arteries, complex coronary lesions, previous coronary artery bypass grafting, or rotational atherectomy procedures [7,[16][17][18]. Studies assessing CAP presented significantly higher morbidity and mortality compared to an uncomplicated PCI, with a potential of an improvement of outcomes post-CS implantation [5,8,19]. The implantation of CS is a standard of care in patients with persistent CAP bleeding.…”
Section: Discussionmentioning
confidence: 99%
“…During a one-year follow-up, they found a high number of adverse events with 3.6% of ST and 34.3% of MACE, respectively. In another study, Hachinohe et al [ 19 ] assessed CSs performance in 53 CAPs lesions, with 81% of Graftmaster (Abbot Vascular, Santa Clara, CA) stents used. During a 1-year follow-up, the authors noted 19.6% TLRs, followed by 41.6% at 10-years and 11.9% STs at one year followed by 23.9% at 10-years.…”
Section: Discussionmentioning
confidence: 99%
“…RECOVERS studies [25] have found similar results, and the incidence of subacute thrombosis within 30 days of PTFE stent placement was higher than that of traditional stent placement. Hachinohe et al [26] performed a retrospective study of 190 patients implanted with PTFE-covered stents over 20 years and found that target vessel myocardial infarction, occlusion, revascularization and in-stent thrombosis events occurred at the early stage after stent implantation, and their incidence increased gradually in the long-term follow-up.…”
Section: Discussionmentioning
confidence: 99%